About 455,000 results
Open links in new tab
  1. HRD vs. BRCA - same or different? - Ovarian Cancer Community

    The BRCA mutation is an HRD mutation (homologous recombination deficiency mutation) - it is the most common HRD mutation. You can be HRD positive and BRCA negative. Studies have …

  2. Anyone long-term survivor without maintenance therapy?

    Sep 24, 2025 · Not as easy to get a parp after recurrence anymore, especially for BRCA negative/HRD negative. My doctor convinced me to try a parp despite minimal expected …

  3. How do I know if my mom is HRD+ - Ovarian Cancer Community

    May 29, 2021 · When I was diagnosed in 2017, the recommendation was for every woman diagnosed with ovarian cancer to have genetic testing for BRCA mutations. If you have the …

  4. Free Webinar Series: Testing for HRD in Cancer

    Sep 17, 2024 · FYI, a 3 part series on Homologous Recombination Deficiency testing in cancer care. Sponsored by the Association for Molecular Pathology in

  5. Does insurance cover HRD testing? - Ovarian Cancer Community

    Will Insurance cover HRD testing? I am on Medicare and have a good supplemental;

  6. HRD vs. BRCA - same or different? - Ovarian Cancer Community

    Mar 24, 2020 · My Mom just had her debulking surgery in January and sample tumor tissue was sent for genetic testing. My understanding is that she tested negative for the BRCA mutation …

  7. Avastin + Rubraca - Ovarian Cancer Community - Inspire

    Jun 10, 2020 · I'm HGSOC, BRCA negative & HRD negative but HRD testing today is still in it's infancy and can be very inaccurate. I have some mutations that my onc still suspects makes …

  8. General thoughts on the tools oncologist have in their toolbox ...

    Sep 30, 2025 · Testing is done on tumor tissue to confirm HER2 status. Disease Stage: Unresectable (cannot be surgically removed) or metastatic (spread to other parts of the body) …

  9. Stage 4A - Chances of recurrence - Ovarian Cancer Community

    Feb 18, 2024 · Even viable tissue for HRD testing was not available. That's a very good prognostic marker as it shows that the tumor was highly platinum sensitive. The other …

  10. Who does tumor testing for Parp Inhibitors? - Inspire

    Jun 26, 2019 · Unfortunately, I didn't know to ask at the time, but found out their testing doesn't include sensitivity to Parp Inhibitors based on HRD (Homologous Recombination Deficiency) …